Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Dec;24(6):888–891. doi: 10.1128/aac.24.6.888

Oral antiviral drugs in experimental herpes simplex keratitis.

H E Kaufman, E D Varnell, Y M Centifanto-Fitzgerald, E De Clercq, G E Kissling
PMCID: PMC185402  PMID: 6318664

Abstract

Chronic oral administration of acyclovir or bromovinyl deoxyuridine to rabbits did not prevent recurrence of virus shedding or clinical corneal disease, nor did it alter the clinical course of recurrences of ocular herpetic disease or result in the appearance of resistant virus in tears.

Full text

PDF
888

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Field H. J. Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy. Antimicrob Agents Chemother. 1982 May;21(5):744–752. doi: 10.1128/aac.21.5.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. KAUFMAN H. E., HEIDELBERGER C. THERAPEUTIC ANTIVIRAL ACTION OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE IN HERPES SIMPLEX KERATITIS. Science. 1964 Aug 7;145(3632):585–586. doi: 10.1126/science.145.3632.585. [DOI] [PubMed] [Google Scholar]
  3. Kaufman H. E., Centifanto-Fitzgerald Y. M., Varnell E. D. Herpes simplex keratitis. Ophthalmology. 1983 Jun;90(6):700–706. doi: 10.1016/s0161-6420(83)34518-8. [DOI] [PubMed] [Google Scholar]
  4. Kaufman H. E., Meyer R. F., Laibson P. R., Waltman S. R., Nesburn A. B., Shuster J. J. Human leukocyte interferon for the prevention of recurrences of herpetic keratitis. J Infect Dis. 1976 Jun;133 (Suppl):A165–A168. doi: 10.1093/infdis/133.supplement_2.a165. [DOI] [PubMed] [Google Scholar]
  5. Nesburn A. B., Willey D. E., Trousdale M. D. Effect of intensive acyclovir therapy during artificial reactivation of latent herpes simplex virus. Proc Soc Exp Biol Med. 1983 Mar;172(3):316–323. doi: 10.3181/00379727-172-41563. [DOI] [PubMed] [Google Scholar]
  6. Nilsen A. E., Aasen T., Halsos A. M., Kinge B. R., Tjøtta E. A., Wikström K., Fiddian A. P. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet. 1982 Sep 11;2(8298):571–573. doi: 10.1016/s0140-6736(82)90658-4. [DOI] [PubMed] [Google Scholar]
  7. Shuster J. J., Kaufman H. E., Nesburn A. B. Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease. Am J Ophthalmol. 1981 Mar;91(3):328–331. doi: 10.1016/0002-9394(81)90285-3. [DOI] [PubMed] [Google Scholar]
  8. Wellings P. C., Awdry P. N., Bors F. H., Jones B. R., Brown D. C., Kaufman H. E. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol. 1972 Jun;73(6):932–942. doi: 10.1016/0002-9394(72)90463-1. [DOI] [PubMed] [Google Scholar]
  9. de Clercq E., Zhang Z. X., Sim I. S. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice. Antimicrob Agents Chemother. 1982 Sep;22(3):421–425. doi: 10.1128/aac.22.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES